Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma

European Urology Focus

Volumn 2, Issue 2, 2016, Pages 210-218

  Butz, Henriett ^a,b   Nofech Mozes, Roy ^a   Ding, Qiang ^a   Khella, Heba W Z ^a   Szabó, Peter M ^c   Jewett, Michael ^d   Finelli, Antonio ^d   Lee, Jason ^e   Ordon, Michael ^e   Stewart, Robert ^e   Krylov, Sergey ^f   Yousef, George M ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f YORK UNIVERSITY   (Canada)

Author keywords

Cell cell communication; Exosomes; MiRNAs; Noninvasive biomarker; Renal cell carcinoma; Urine

Indexed keywords

CELL FREE RNA; EXOSOMAL MICRORNA; EXOSOMAL RNA; MICRORNA; MICRORNA 1183; MICRORNA 126 3P; MICRORNA 150 5P; MICRORNA 17 5P; MICRORNA 21 3P; MICRORNA 21 5P; MICRORNA 25 3P; MICRORNA 34B 5P; MICRORNA 449A; MICRORNA 486 5P; RNA; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CELL COMMUNICATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENDOTHELIUM CELL; EXOSOME; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY SURGERY; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; RENAL CANCER CELL LINE; RNA ANALYSIS; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; URINALYSIS; VALIDATION PROCESS;

EID: 84969759571     PISSN: None     EISSN: 24054569     Source Type: Journal    
DOI: 10.1016/j.euf.2015.11.006     Document Type: Article

References (30)

1. Russo P. Contemporary understanding and management of renal cortical tumors. Urol Clin North Am 2008, 35:13-17.
2. Kurban G., Gedye C., Morales C., Yousef G.M., Almatar A., Jewett M.A. Diagnosis and treatment of small renal masses: the role for molecular biology. Arch Esp Urol 2013, 66:505-516.
3. Arsanious A., Bjarnason G.A., Yousef G.M. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Mol Cancer 2009, 8:20.
4. Schaefer A., Stephan C., Busch J., Yousef G.M., Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 2010, 7:286-297.
5. Lichner Z., Saleh C., Subramaniam V., Seivwright A., Prud'homme G.J., Yousef G.M. miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/tumor initiating cell properties. Oncotarget 2014, 6:5567-5581.
6. Weber J.A., Baxter D.H., Zhang S., et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010, 56:1733-1741.
7. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011, 39:7223-7233.
8. Huang X., Liang M., Dittmar R., Wang L. Extracellular microRNAs in urologic malignancies: chances and challenges. Int J Mol Sci 2013, 14:14785-14799.
9. Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep 2011, 3:15.
10. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
11. Butz H., Liko I., Czirjak S., et al. MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas. Pituitary 2011, 14:112-124.
12. White N.M., Bao T.T., Grigull J., et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 2011, 186:1077-1083.
13. von Brandenstein M., Pandarakalam J.J., Kroon L., et al. MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol 2012, 180:1787-1797.
14. Redova M., Poprach A., Nekvindova J., et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 2012, 10:55.
15. Zhao A., Li G., Peoc'h M., Genin C., Gigante M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol 2013, 94:115-120.
16. Wulfken L.M., Moritz R., Ohlmann C., et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 2011, 6:e25787.
17. Raimondo F., Morosi L., Corbetta S., et al. Differential protein profiling of renal cell carcinoma urinary exosomes. Mol Biosyst 2013, 9:1220-1233.
18. Juan D., Alexe G., Antes T., et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010, 75:835-841.
19. Jung M., Mollenkopf H.J., Grimm C., et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009, 13:3918-3928.
20. Vogt M., Munding J., Gruner M., et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch 2011, 458:313-322.
21. Chen H., Lin Y.W., Mao Y.Q., et al. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett 2012, 320:40-47.
22. Tahiri A., Leivonen S.K., Luders T., et al. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis 2014, 35:76-85.
23. Slaby O., Redova M., Poprach A., et al. Identification of microRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer 2012, 51:707-716.
24. Vergho D., Kneitz S., Rosenwald A., et al. Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC Cancer 2014, 14:25.
25. Khella H.W., White N.M., Faragalla H., et al. Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumour Biol 2012, 33:131-140.
26. Yang C., Robbins P.D. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011, 2011:842849.
27. Liu Y., Zhao L., Li D., et al. Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development. Protein Cell 2013, 4:932-941.
28. Li J., Zhang Y., Liu Y., et al. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J Biol Chem 2013, 288:23586-23596.
29. Yang L., Wu X., Wang D., Luo C., Chen L. Renal carcinoma cell-derived exosomes induce human immortalized line of Jurkat T lymphocyte apoptosis in vitro. Urol Int 2013, 91:363-369.
30. Jiang X.L., Zhang Y., Tan B., Luo C.L., Wu X.H. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in ap-AKT-dependent manner. Neoplasma 2014, 61:416-423.